Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose (Q30558271)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

8

object named as

Rainer Storb

1 reference

Europe PubMed Central

19 August 2017

PMC publication ID

Brenda M Sandmaier

2

object named as

Brenda M Sandmaier

1 reference

Europe PubMed Central

19 August 2017

PMC publication ID

10

object named as

Barry Storer

1 reference

Europe PubMed Central

19 August 2017

PMC publication ID

Thomas R Chauncey

6

object named as

Thomas Chauncey

1 reference

Europe PubMed Central

19 August 2017

PMC publication ID

David G. Maloney

9

object named as

David G Maloney

1 reference

Europe PubMed Central

19 August 2017

PMC publication ID

7

object named as

Paul J Martin

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1

object named as

Merav Bar

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Parameswaran Hari

5

object named as

Parameswaran Hari

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Benedetto Bruno

4

object named as

Benedetto Bruno

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Yoshihiro Inamoto

3

object named as

Yoshihiro Inamoto

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Mary E D Flowers

11

object named as

Mary E D Flowers

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

publication date

21 March 2013

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

19

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

949-957

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

Reduced mortality after allogeneic hematopoietic-cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

Molecules and mechanisms of the graft-versus-leukaemia effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

The current status of hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

Graft-versus-leukemia reactions after bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

20 June 2018

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

26 November 2018

Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

26 November 2018

Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

26 November 2018

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

26 November 2018

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

26 November 2018

Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3846289

26 November 2018

Donor leukocyte infusions for multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High Response Rate to Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Indolent Non-Hodgkin Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor leukocyte infusions in acute lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23523892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2013.03.001

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30558271&oldid=1964361250"